Table 2 Correlation of PRDM1 and miR-223 expression with clinical factors and prognostic value

Patients

61

31

male

34

55.74

26

8

0.829

19

61.29

5

14

0.704

female

27

44.26

20

7

12

38.71

4

8

Age (year)

61

31

<40

29

47.54

21

8

0.463

13

41.94

4

9

NA^※

40-60

20

32.79

17

3

11

35.48

2

9

>60

12

19.67

8

4

7

22.58

2

5

Stage ^∆

46

26

І/ІІ

18

39.13

9

9

0.009

9

34.62

3

6

0.661

III/IV

28

60.87

24

4

17

65.38

4

13

Outcome

35

21

alive

12

34.29

6

6

0.038

8

38.10

3

5

0.325

dead

23

65.71

20

3

13

61.90

2

11

5-year OS

35

21

Mean ± SD

39.49 ± 9.62

64.02 ± 11.48

0.045

53.40 ± 18.41

45.70 ± 10.05

0.504

OS

35

21

Mean ± SD

44.72 ± 10.41

64.02 ± 11.48

0.084

53.40 ± 18.41

52.84 ± 10.70

0.784

FFS

35

21

Mean ± SD

26.50 ± 5.60

57.41 ± 11.60

0.042

43.20 ± 16.89

38.99 ± 7.84

0.691